Clinical trial
Role of Nasal Dysbiosis in Parkinson Disease
NCT04249245 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Nasal Dysbiosis in Parkinson Disease
- Lead sponsor
- Institut Pasteur
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 14, 2020
- Completion date
- April 25, 2024
- Enrollment
- 285 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.